<p>TORONTO, Canada — The United States Food and Drug Administration has issued a warning letter to a company that appears to sell products containing human fecal matter without approval from the a
</p><p>This type of therapy should only be used in the context of an authorized clinical trial, or to treat patients with recurrent Clostridium difficile, also known as C.
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب: